vs
Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and Information Services Group Inc. (III). Click either name above to swap in a different company.
Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $32.6M, roughly 1.9× ASCENTAGE PHARMA GROUP INTERNATIONAL).
Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
AAPG vs III — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $61.2M |
| Net Profit | $11.4M | $2.7M |
| Gross Margin | 90.7% | — |
| Operating Margin | — | 8.2% |
| Net Margin | — | 4.4% |
| Revenue YoY | — | 2.7% |
| Net Profit YoY | — | 82.5% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $61.2M | ||
| Q4 25 | — | $61.2M | ||
| Q3 25 | — | $62.4M | ||
| Q2 25 | $32.6M | $61.6M | ||
| Q1 25 | — | $59.6M | ||
| Q4 24 | — | $57.8M | ||
| Q3 24 | — | $61.3M | ||
| Q2 24 | — | $64.3M |
| Q1 26 | — | $2.7M | ||
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $3.1M | ||
| Q2 25 | $11.4M | $2.2M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $2.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 44.8% | ||
| Q3 25 | — | 42.2% | ||
| Q2 25 | 90.7% | 42.2% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 39.5% |
| Q1 26 | — | 8.2% | ||
| Q4 25 | — | 8.4% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.7% |
| Q1 26 | — | 4.4% | ||
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 3.2% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | — | $0.06 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $0.04 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAPG
| Products | $29.7M | 91% |
| Others | $2.9M | 9% |
III
Segment breakdown not available.
